GlassScriptPhysician profile
Seychelle Prentice
NPI 1275091928
$2,292.69
in general payments reported to CMS, 2019-2025
21 companies · $793 in 2025
The $793 reported for 2025 was more than what 79% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $80.00 · 2022: $163 · 2023: $462 · 2024: $795 · 2025: $793.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,050.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,049.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $336.85 | 2022-2025 | Brilinta, Lokelma, Farxiga |
| Janssen Pharmaceuticals, INC | $226.23 | 2021-2024 | Xarelto |
| Amgen INC. | $202.07 | 2022-2025 | Repatha, Repatha |
| Novartis Pharmaceuticals Corporation | $190.70 | 2022-2025 | |
| Alnylam Pharmaceuticals INC. | $177.61 | 2024-2025 | Amvuttra, Onpattro |
| Boehringer Ingelheim Pharmaceuticals, INC. | $166.36 | 2023-2025 | Jardiance |
| Cvrx, INC. | $146.87 | 2023 | Barostim Neo System |
| Biosense Webster, INC. | $125.00 | 2024 | Carto 3 |
| Kestra Medical Technology Services, INC. | $118.83 | 2025 | Assure Wcd |
| Pfizer INC. | $104.78 | 2024-2025 | |
| Scpharmaceuticals INC. | $88.00 | 2024-2025 | |
| Medtronic, INC. | $81.04 | 2024 | Linq II |
| Esperion Therapeutics, INC. | $65.06 | 2024-2025 | Nexletol |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $55.91 | 2024-2025 | Lifevest |
| Merck Sharp & Dohme LLC | $54.18 | 2025 | Verquvo |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $47.35 | 2022-2023 | Ozempic, Rybelsus |
| Boston Scientific Corporation | $23.90 | 2024 | Watchman Flx |
| Sanofi-Aventis U.S. LLC | $23.54 | 2023 | |
| Genzyme Corporation | $21.15 | 2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $20.43 | 2025 | |
| E.R. Squibb & Sons, L.L.C. | $16.83 | 2025 | Camzyos |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Seychelle Prentice listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.